Holen Sie sich die Stockscreener-App
0.7023
0.23%
-0.0067
Handel nachbörslich:
.69
-0.0123
-1.75%
Envoy Medical Inc Aktie (COCH) Neueste Nachrichten
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology - Florida Hospital News and Healthcare Report
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SurpriseLow Estimate Range - Newser
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Progress, Though Revenue Absence Raises QuestionsHigh Growth Earnings - Newser
Envoy Medical Inc. (COCH) Q1 2026 Earnings: Strong EPS Beat Amidst Pre-Revenue StageEarnings Per Share - Newser
Envoy Medical Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue, Stock DeclinesTrading Community Hub - Newser
COCH Q1 2026 Earnings: Significant EPS Beat Amid Revenue UncertaintyElite Trading Signals - Newser
Envoy Medical Granted Extension to Regain Nasdaq Compliance - TipRanks
Envoy Medical Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Envoy Medical (NASDAQ: COCH) granted more time to meet Nasdaq $1 bid rule - Stock Titan
COCH Q1 2026 Earnings: Narrower Loss Beats Estimates as Envoy Medical AdvancesReturn On Assets - Newser
COCH Q1 2026 Earnings: EPS Beats Estimates Despite Pre-Revenue Status, Stock DeclinesShared Buy Zones - Newser
Envoy Medical shareholders approve plan amendments and board elections at annual meeting By Investing.com - Investing.com South Africa
Envoy Medical shareholders approve plan amendments and board elections at annual meeting - Investing.com Australia
Envoy Medical Shareholders Expand Equity and Governance Plans - TipRanks
Envoy Medical (NASDAQ: COCH) holders back larger equity and stock purchase plans - Stock Titan
Envoy Medical (COCH): Nantahala reports 9.99% position in company - Stock Titan
[SCHEDULE 13G] Envoy Medical, Inc. Passive Investment Disclosure (>5%) - Stock Titan
TradingKey - TradingKey
Envoy Medical Flags Limited Risk Detail, Urges Investors to Review 2026 Form 10-K for Key Uncertainties - TipRanks
ENVOY MEDICAL (COCH) insiders report 2.46M warrants, 3.10% stake - Stock Titan
Envoy Medical, Inc. Q1 2026 Financial Report: Earnings, Balance Sheet, and FDA-Approved Hearing Devices Overview - Minichart
Envoy Medical completes pivotal trial enrollment, raises $78m By Investing.com - Investing.com South Africa
Envoy Medical Achieves Pivotal Trial Milestone and Secures $78M Financing for Fully Implanted Cochlear Implant FDA Approval Progress - Minichart
Envoy Medical completes pivotal trial enrollment, raises $78m - Investing.com
Envoy Medical, Inc. 1Q 2026: Revenue $39K, Net income ($5.7M), EPS ($0.08) — 10-Q Summary - TradingView
Envoy Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Envoy Medical (NASDAQ: COCH) Q1 2026 loss narrows after $27.8M raise - Stock Titan
Envoy Medical reports Q1 2026: $39k revenue, $5.96M operating expenses, $4.35M net loss - TradingView
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant - marketscreener.com
Envoy Medical (NASDAQ: COCH) boosts cash to $25M as pivotal trial fully enrolls - Stock Titan
56 people get first-of-its-kind fully implanted cochlear implant - Stock Titan
COCHW (Envoy Med) warrant earnings report draws market scrutiny amid limited financial disclosure.Margin Expansion - newser.com
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio - TMX Newsfile
Envoy Medical Reports on First Quarter 2025 Results - TMX Newsfile
Envoy Medical Corporation and Anzu Special Acquisition Corp I Complete Business Combination - TMX Newsfile
Envoy Medical to Participate in the 37th Annual ROTH Conference - TMX Newsfile
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results - Quantisnow
Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up - TMX Newsfile
Envoy Medical (COCH) Expected to Announce Earnings on Thursday - MarketBeat
Envoy Medical presents early data from cochlear implant trial By Investing.com - Investing.com Nigeria
Envoy Medical presents early data from cochlear implant trial - Investing.com
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant - Yahoo Finance
Envoy Medical Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - Florida Hospital News and Healthcare Report
Envoy Med (COCH) Stock Industry Update (Selling Pressure) 2026-04-27Shared Momentum Picks - newser.com
Envoy Medical shares crater after announcing $4 million direct offering - MSN
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial - TMX Newsfile
COCH (Envoy Medical Inc.) reports Q3 2025 EPS below analyst estimates, as shares rise one percent in daily trading.Special Dividend - Cổng thông tin điện tử tỉnh Tây Ninh
A fully implanted cochlear implant clears key step in 56-patient study - Stock Titan
COCHW | Envoy Medical, Inc Warrant Insider Trading - Quiver Quantitative
1.35%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):